Insider · CIK 0001579377
Guy Archibald Innes
Files at VNRX (VOLITIONRX LTD). First filing Nov 24, 2023, latest Oct 15, 2025.
In brief
Guy Archibald Innes files SEC Form 4 as director at VNRX (VOLITIONRX LTD). Since Nov 24, 2023, Guy Archibald Innes has reported 8 open-market buys worth $347k and 0 open-market sells worth $0, the latest filed on Oct 15, 2025.
After Guy Archibald Innes's past buys, the stock trailed the S&P 500 by a median 66.3% over six months (n = 5), and 0% of those buys were ahead of the index at six months. InsiderTell labels that a negative record.
The newest scored trade: bought $49k of VNRX on Oct 14, 2025, filed Oct 15, 2025, scored 63 (notable). In the last 12 months: 1 buy worth $49k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VNRX: VOLITIONRX LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | VOLITIONRX LTD | $49k 96,153 shares | +10% | +10% from low-50% from high | |
| 46Moderate | VOLITIONRX LTD | $50k 78,125 shares | +9% | +52% from low-30% from high | |
| 36Weak | VOLITIONRX LTD | $11k 20,000 shares | +2% | +29% from low-39% from high | |
| 31Weak | VNRXbuy VOLITIONRX LTD | $100k 181,818 shares | +26% | - | |
| 46Moderate | VOLITIONRX LTD | $100k 174,764 shares | +40% | - | |
| 38Weak | VOLITIONRX LTD | $15k 20,000 shares | +3% | +24% from low-71% from high | |
| 38Weak | VOLITIONRX LTD | $7,600 10,000 shares | +2% | +19% from low-72% from high | |
| 33Weak | VOLITIONRX LTD | $14k 20,000 shares | +3% | +18% from low-73% from high |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +178,000 | $0.00 | $0 | 1,252,967 | Feb 27, 2026 |
| Jan 22, 2026 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +12,000 | $0.00 | $0 | 1,074,967 | Jan 23, 2026 |
| Oct 14, 2025 | VNRX VOLITIONRX LTD | POpen-market purchase Common Stock | +96,153 | $0.51 | $49k | 1,062,967 | Oct 15, 2025 |
| Oct 14, 2025 | VNRX VOLITIONRX LTD | POpen-market purchase Warrant (Right to Buy)derivative | +96,153 | $0.01 | $962 | 96,153 | Oct 15, 2025 |
| Aug 5, 2025 | VNRX VOLITIONRX LTD | POpen-market purchase Common Stock | +78,125 | $0.64 | $50k | 966,814 | Aug 6, 2025 |
| Jun 3, 2025 | VNRX VOLITIONRX LTD | POpen-market purchase Common Stock | +20,000 | $0.54 | $11k | 888,689 | Jun 4, 2025 |
| Mar 26, 2025 | VNRX VOLITIONRX LTD | POpen-market purchase Common Stock | +181,818 | $0.55 | $100k | 868,689 | Mar 27, 2025 |
| Mar 1, 2025 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +19,786 | $0.00 | $0 | 686,871 | Mar 4, 2025 |
| Jan 29, 2025 | VNRX VOLITIONRX LTD | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | - | - | 0 | Jan 31, 2025 |
| Jan 29, 2025 | VNRX VOLITIONRX LTD | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | - | - | 25,000 | Jan 31, 2025 |
| Jan 15, 2025 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 667,085 | Jan 17, 2025 |
| Dec 9, 2024 | VNRX VOLITIONRX LTD | POpen-market purchase Common Stock | +174,764 | $0.57 | $100k | 617,085 | Dec 10, 2024 |
| Dec 1, 2024 | VNRX VOLITIONRX LTD | AGrant or award Common Stock | +17,296 | $0.00 | $0 | 442,321 | Dec 3, 2024 |
| Nov 27, 2023 | VNRX VOLITIONRX LTD | POpen-market purchase Common Stock | +20,000 | $0.77 | $15k | 627,161 | Nov 28, 2023 |
| Nov 24, 2023 | VNRX VOLITIONRX LTD | POpen-market purchase Common Stock | +10,000 | $0.76 | $7,600 | 607,161 | Nov 27, 2023 |
| Nov 22, 2023 | VNRX VOLITIONRX LTD | POpen-market purchase Common Stock | +20,000 | $0.71 | $14k | 597,161 | Nov 24, 2023 |
Questions about Guy Archibald Innes
Answered from the filings on this page, as of the latest one.
Is Guy Archibald Innes buying or selling?
In the last 12 months Guy Archibald Innes reported 1 open-market buy worth $49k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $49k of VNRX on Oct 14, 2025. Grants, option exercises and tax withholding are not counted.
How did Guy Archibald Innes's past buys perform?
Measured from the first close after each filing, the stock trailed the S&P 500 by a median 66.3% over six months across 5 past buys, with 0% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Guy Archibald Innes file Form 4?
Guy Archibald Innes has filed Form 4 at VNRX (VOLITIONRX LTD). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.